Draft Guidance Addresses Crossover Risk of Male API Use to Potential Offspring

Drug Industry Daily
A A
The FDA wants drugmakers to assess the risks of active pharmaceutical ingredients taken by men on the development of embryos and fetuses of their female partners.

To View This Article:

Login

Subscribe To Drug Industry Daily